Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Osteoporosis

  Free Subscription


14.01.2019

2 J Bone Miner Res
8 Osteoporos Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    J Bone Miner Res

  1. TATANGELO G, Watts J, Lim K, Connaughton C, et al
    The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017.
    J Bone Miner Res. 2019 Jan 7. doi: 10.1002/jbmr.3640.
    PubMed     Text format     Abstract available

  2. ZHAO X, Ning L, Xie Z, Jie Z, et al
    The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice.
    J Bone Miner Res. 2019 Jan 7. doi: 10.1002/jbmr.3655.
    PubMed     Text format     Abstract available


    Osteoporos Int

  3. WATSON SL, Weeks BK, Weis LJ, Harding AT, et al
    High-intensity exercise did not cause vertebral fractures and improves thoracic kyphosis in postmenopausal women with low to very low bone mass: the LIFTMOR trial.
    Osteoporos Int. 2019 Jan 5. pii: 10.1007/s00198-018-04829.
    PubMed     Text format     Abstract available

  4. LAMY O, Fernandez-Fernandez E, Monjo-Henry I, Stoll D, et al
    Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.
    Osteoporos Int. 2019 Jan 6. pii: 10.1007/s00198-018-04820.
    PubMed     Text format     Abstract available

  5. RUDMAN HA, Birrell F, Pearce MS, Tuck SP, et al
    Obesity, bone density relative to body weight and prevalent vertebral fracture at age 62 years: the Newcastle thousand families study.
    Osteoporos Int. 2019 Jan 8. pii: 10.1007/s00198-018-04817.
    PubMed     Text format     Abstract available

  6. STOLZENBERG N, Felsenberg D, Belavy DL
    Postural control is associated with muscle power in post-menopausal women with low bone mass.
    Osteoporos Int. 2018;29:2283-2288.
    PubMed     Text format     Abstract available

  7. MORIWAKI K, Fukuda H
    Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
    Osteoporos Int. 2019 Jan 4. pii: 10.1007/s00198-018-4798.
    PubMed     Text format     Abstract available

  8. NAYLOR KE, McCloskey EV, Jacques RM, Peel NFA, et al
    Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis.
    Osteoporos Int. 2019 Jan 6. pii: 10.1007/s00198-018-04823.
    PubMed     Text format     Abstract available

  9. NAYAK S, Greenspan SL
    A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk.
    Osteoporos Int. 2019 Jan 8. pii: 10.1007/s00198-018-4791.
    PubMed     Text format     Abstract available

  10. BLIUC D, Tran T, van Geel T, Adachi JD, et al
    Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study.
    Osteoporos Int. 2019 Jan 3. pii: 10.1007/s00198-018-4806.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: